FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When Henry VIII was diagnosed, it became firmly entrenched in popular belief ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

Many people with depression do not seek treatment, although the majority can benefit from treatment. A number of preliminary studies suggest that certain natural remedies for depression may work well ...

LOS ANGELES—Noah Hudnut’s family had already spent $150,000 on his psychiatric care when he was hauled in handcuffs by police to the emergency room of UCLA medical center. On top of the ...

Febuxostat Open-label Clinical Trial of Urate-lowering Efficacy and Safety Adverse events were similar across all treatment groups ... febuxostat 120-mg, and allopurinol groups, respectively.

Add articles to your saved list and come back to them any time. Teenage sprint sensation Gout Gout will pocket more than $6 million from adidas in a lucrative multi-year deal with the sporting ...

Achieving serum urate to below 6 mg/dL with urate-lowering therapy (ULT) in patients with gout and chronic kidney ... adhered to other treatments more consistently, and used ULT for a longer ...